Efficacy of Upfront Docetaxel With Androgen Deprivation Therapy for Castration-Sensitive Metastatic Prostate Cancer Among Minority Patients

医学 雄激素剥夺疗法 前列腺癌 危险系数 多西紫杉醇 内科学 肿瘤科 比例危险模型 置信区间 癌症
作者
Surabhi Pathak,Romy Jose Thekkekara,Udit Yadav,Ahmed Tarig Ahmed,Barbara Yim,Thomas E. Lad,Michael Russell Mullane,Kumar Kunnal Batra,Wilbert S. Aronow,Sarah P. Psutka
出处
期刊:American Journal of Therapeutics [Lippincott Williams & Wilkins]
卷期号:28 (4): e380-e387 被引量:2
标识
DOI:10.1097/mjt.0000000000001085
摘要

Upfront docetaxel (UD) with androgen deprivation therapy (ADT) has been demonstrated to improve survival outcomes in metastatic castration-sensitive prostate cancer (mCSPC). However, existing studies have included predominantly Caucasian patients.To compare the efficacy of addition of UD to ADT in mCSPC to ADT alone among minority patients.Retrospective study of mCSPC patients.Patients treated with UD and ADT between January 2014 and December 2017 (UD + ADT, n = 44) were compared with those treated with ADT alone between January 2008 and January 2017 (ADT, n = 38); patients of Caucasian ethnicity were excluded. The outcome of interest was progression-free survival (PFS), which was estimated using Kaplan-Meier analysis and Cox proportional hazard analysis.Overall, 63 (76.8%) patients were African American and 16 (19.5%) were Hispanic. Fifty-five (67%) patients had high-volume mCSPC. The median follow-up was 14 months [95% confidence interval (CI): 10.4-16.5] for UD + ADT and 42 months (95% CI: 17-66.9) for ADT. Median PFS did not differ between groups: UD + ADT: 16 versus ADT: 18 months [hazard ratio (HR) for UD + ADT = 0.88, 95% CI: 0.48-1.62; P = 0.70]. In patients with high-volume disease, median PFS remained similar (UD + ADT: 16 vs. ADT: 14 months (HR for UD + ADT = 0.64, 95% CI: 0.33-1.25; P = 0.19). On multivariable analysis, prolonged time to nadir PSA, HR = 0.83 (95% CI: 0.76-0.90), was independently associated with PFS. The most common toxicities in UD + ADT were anemia and fatigue. Major limitations include small sample size and potential for selection bias due to the retrospective study design.In this retrospective review of a minority mCSPC cohort, UD + ADT was not associated with improved PFS compared with ADT alone. Although further study with larger sample size is needed, these results underscore the importance of ensuring accrual of minorities in clinical trials, reflective of the real-world setting.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
云然发布了新的文献求助10
刚刚
泊凉少年发布了新的文献求助10
1秒前
1秒前
卡拉肖克攀完成签到,获得积分10
2秒前
优雅的盼旋完成签到,获得积分10
2秒前
hugdoggy完成签到,获得积分10
3秒前
大气糖豆完成签到 ,获得积分10
3秒前
在水一方的应助被王冬瓜采纳,获得30
4秒前
4秒前
4秒前
孟翔发布了新的文献求助10
4秒前
海绵宝宝发布了新的文献求助10
6秒前
丁驰完成签到,获得积分10
7秒前
monica完成签到,获得积分10
7秒前
经十路以东的应助被闪闪香魔采纳,获得10
8秒前
gky完成签到,获得积分10
8秒前
nana发布了新的文献求助10
9秒前
菜鸡5号完成签到,获得积分10
9秒前
小栗发布了新的文献求助10
10秒前
10秒前
10秒前
11秒前
科目三的应助被忆修采纳,获得10
11秒前
11秒前
11秒前
科研通AI6.2的应助被ZhaoPeng采纳,获得30
12秒前
12秒前
12秒前
14秒前
14秒前
15秒前
15秒前
HB发布了新的文献求助10
15秒前
xiaoshuai发布了新的文献求助10
16秒前
16秒前
lsq发布了新的文献求助10
17秒前
英俊的铭的应助被海绵宝宝采纳,获得10
17秒前
蝴蝶兰完成签到,获得积分10
17秒前
GG发布了新的文献求助10
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Rosenblum, Global Change Biology 800
自動車の空力技術 800
Organizational Behavior 510
Management and the Arts 510
Geschichtliche Grundbegriffe (GGB), Band 5: Pro–Soz 300
Die Religion in Geschichte und Gegenwart (RGG), 4. Auflage, Band 7: R–S 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7789956
求助须知:如何正确求助?哪些是违规求助? 9327529
关于积分的说明 20418828
捐赠科研通 7379491
什么是DOI,文献DOI怎么找? 3322957
关于科研通互助平台的介绍 2470892
邀请新用户注册赠送积分活动 2339810